DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$90.49
+4.46 (+5.18%)
Performance
1D
—
1W
+10.02%
1M
+10.94%
3M
-16.59%
6M
+5.54%
1Y
+147.17%
YTD
+128.05%
Open$88.22
Previous Close$86.03
Day High$91.83
Day Low$84.41
52W High$117.88
52W Low$32.42
Volume—
Avg Volume874.0K
Market Cap4.76B
P/E Ratio—
EPS$-4.15
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$90.05
Above
SMA 200
$85.95
Above
RSI (14)
75.2
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
-57.1% upside
Current
$90.49
$90.49
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.89M | 305.72M | 270.76M |
| Net Income | -230,515,885 | -32,339,215 | -26,813,974 |
| Profit Margin | -7,973.3% | -10.6% | -9.9% |
| EBITDA | -252,505,292 | -32,605,970 | -27,281,394 |
| Free Cash Flow | — | -20,890,110 | -21,520,158 |
| Rev Growth | — | +9.7% | -3.3% |
| Debt/Equity | — | 0.57 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $293.30 | +0.68% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.45 | +0.66% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.25 | +1.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $549.39 | +0.42% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $922.99 | +2.06% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.52 | +0.37% | 7.7 | 20.98B |